Concepedia

Wenge Wang

WW

Statistics

Publications

5

Citations

196

H-Index

5

Active since

2017

Affiliations

Pfizer (United States)(Current)

Akston Biosciences (United States)

Wenge Wang is an author at Pfizer (United States) specializing in high-cell-density culture, bioengineering, and bioreactor design.

ORCID

Publications per year

2017–2023

5

Publications

5

Cell‐controlled hybrid perfusion fed‐batch CHO cell process provides significant productivity improvement over conventional fed‐batch cultures

Gregory Hiller, Ana Maria Ovalle, Matthew Gagnon et al. · Biotechnology and Bioengineering · 2017 · 93 citations

, , +17

Shift to high‐intensity, low‐volume perfusion cell culture enabling a continuous, integrated bioprocess

Matthew Gagnon, Shashikant Nagre, Wenge Wang et al. · Biotechnology Progress · 2018 · 42 citations

, , +16

Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates

Renee Procopio‐Melino, Frank W. Kotch, Amar S. Prashad et al. · Scientific Reports · 2022 · 25 citations · Full text

, , +17

Novel, linked bioreactor system for continuous production of biologics

Matthew Gagnon, Shashikant Nagre, Wenge Wang et al. · Biotechnology and Bioengineering · 2019 · 22 citations

, , +17

Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches

Mingyue Li, V. Beaumont, Shahajahan Akbar et al. · mAbs · 2023 · 14 citations · Full text

, , +16

1–5 of 5